From: Expression analysis of genes and pathways associated with liver metastases of the uveal melanoma
GO item | Fold enrichment | P value |
---|---|---|
Germ cell programmed cell death | 32.29 | 2.80 × 10-3 |
Developmental programmed cell death | 19.37 | 8.95 × 10-3 |
Protein retention in ER lumen | 13.84 | 1.80 × 10-2 |
Germ cell migration | 13.45 | 3.65 × 10-4 |
Melanocyte differentiation | 9.22 | 8.27 × 10-3 |
Mitotic cell cycle spindle assembly checkpoint | 8.81 | 4.36 × 10-2 |
Negative regulation of mitotic metaphase/anaphase transition | 8.81 | 4.36 × 10-2 |
Pigmentation during development | 8.69 | 1.14 × 10-4 |
Pigment cell differentiation | 8.61 | 1.01 × 10-2 |
Antigen processing and presentation of peptide antigen via MHC class I | 7.60 | 1.44 × 10-2 |
Positive regulation of calcium ion transport into cytosol | 6.46 | 2.26 × 10-2 |
Regulation of calcium ion transport into cytosol | 5.57 | 1.16 × 10-2 |
T cell proliferation | 4.78 | 4.95 × 10-2 |
Regulation of transforming growth factor beta receptor signaling pathway | 4.14 | 3.15 × 10-2 |
Positive regulation of homeostatic process | 4.04 | 3.42 × 10-2 |
Response to vitamin A | 3.84 | 4.00 × 10-2 |
Pigmentation | 3.83 | 9.50 × 10-3 |
Mitotic cell cycle checkpoint | 3.75 | 4.30 × 10-2 |
Regulation of calcium ion transport | 3.74 | 5.31 × 10-3 |
Extracellular matrix organization | 3.73 | 3.63 × 10-4 |
Alcohol biosynthetic process | 3.67 | 4.62 × 10-2 |
Regulation of metal ion transport | 3.59 | 3.49 × 10-3 |
Leukocyte mediated immunity | 3.38 | 5.04 × 10-3 |
Cellular response to insulin stimulus | 3.32 | 1.83 × 10-2 |
Regulation of ion transport | 3.26 | 3.51 × 10-3 |
Lymphocyte mediated immunity | 3.23 | 2.09 × 10-2 |
Response to organic cyclic substance | 3.20 | 1.30 × 10-3 |
Response to toxin | 3.18 | 3.98 × 10-2 |
Double-strand break repair | 3.12 | 4.23 × 10-2 |
Sphingolipid metabolic process | 3.01 | 2.82 × 10-2 |
Response to molecule of bacterial origin | 3.00 | 1.70 × 10-2 |
Adaptive immune response | 2.94 | 3.16 × 10-2 |
Response to lipopolysaccharide | 2.94 | 3.16 × 10-2 |
Adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.94 | 3.16 × 10-2 |
Cellular response to hormone stimulus | 2.91 | 2.77 × 10-3 |
Response to insulin stimulus | 2.91 | 1.22 × 10-2 |
Membrane lipid metabolic process | 2.79 | 3.91 × 10-2 |
Activation of MAPK activity | 2.76 | 4.11 × 10-2 |
Immune effector process | 2.65 | 8.66 × 10-3 |
Protein processing | 2.59 | 2.27 × 10-2 |
Extracellular structure organization | 2.57 | 4.72 × 10-3 |
Response to oxidative stress | 2.56 | 4.95 × 10-3 |
Positive regulation of MAP kinase activity | 2.53 | 3.86 × 10-2 |
Regulation of MAP kinase activity | 2.52 | 1.21 × 102 |
Amine transport | 2.46 | 2.99 × 10-2 |
Camera-type eye development | 2.41 | 4.79 × 10-2 |
Carbohydrate biosynthetic process | 2.41 | 4.79 × 10-2 |
Protein oligomerization | 2.41 | 7.85 × 10-3 |
Protein maturation | 2.38 | 3.54 × 10-2 |
Nucleotide biosynthetic process | 2.26 | 1.29 × 102 |
Nucleobase, nucleoside and nucleotide biosynthetic process | 2.17 | 1.69 × 10-2 |
Nucleobase, nucleoside, nucleotide and nucleic acid biosynthetic process | 2.17 | 1.69 × 10-2 |
Cell proliferation | 2.15 | 2.12 × 10-4 |
Muscle organ development | 2.14 | 1.41 × 102 |
Regulation of neurogenesis | 2.14 | 3.34 × 10-2 |
Skeletal system development | 2.13 | 2.21 × 10-3 |
Response to peptide hormone stimulus | 2.10 | 4.96 × 10-2 |
Transmembrane receptor protein tyrosine kinase signaling pathway | 2.02 | 2.20 × 10-2 |
Regulation of nervous system development | 2.02 | 3.63 × 10-2 |
Nitrogen compound biosynthetic process | 1.99 | 5.98 × 10-3 |
Enzyme linked receptor protein signaling pathway | 1.98 | 4.86 × 10-3 |
Response to drug | 1.94 | 3.62 × 10-2 |
Blood vessel development | 1.84 | 4.11 × 10-2 |
Response to DNA damage stimulus | 1.82 | 1.20 × 10-2 |
Induction of apoptosis | 1.82 | 2.14 × 10-2 |
Induction of programmed cell death | 1.81 | 2.19 × 10-2 |
Positive regulation of apoptosis | 1.80 | 7.74 × 10-3 |
Vasculature development | 1.80 | 4.83 × 10-2 |
Positive regulation of programmed cell death | 1.79 | 8.09 × 10-3 |
Positive regulation of cell death | 1.78 | 8.74 × 10-3 |
M phase | 1.77 | 2.70 × 10-2 |
Response to hormone stimulus | 1.76 | 1.98 × 10-2 |
Response to endogenous stimulus | 1.75 | 1.46 × 10-2 |
Cell cycle phase | 1.72 | 1.82 × 10-2 |
Response to abiotic stimulus | 1.67 | 3.73 × 10-2 |
Protein kinase cascade | 1.66 | 3.89 × 10-2 |
Cellular response to stress | 1.65 | 9.67 × 10-3 |
Response to organic substance | 1.61 | 5.45 × 10-3 |
Phosphorylation | 1.57 | 5.41 × 10-3 |
Oxidation reduction | 1.57 | 1.51 × 10-2 |
Phosphate metabolic process | 1.56 | 2.49 × 10-3 |
Phosphorus metabolic process | 1.56 | 2.49 × 10-3 |
Cell cycle process | 1.54 | 2.79 × 10-2 |
Protein amino acid phosphorylation | 1.50 | 2.49 × 10-2 |
Immune response | 1.50 | 2.35 × 10-2 |
Regulation of cell proliferation | 1.44 | 3.02 × 10-2 |
Regulation of programmed cell death | 1.43 | 2.88 × 10-2 |
Regulation of cell death | 1.43 | 3.01 × 10-2 |
Regulation of apoptosis | 1.41 | 3.91 × 10-2 |